Search Results
Apr 29, 2026, 10:14 ET Sagicor Life Insurance Company Appoints Eric Sandberg as President
driving our next phase of growth," said Andre Mousseau, President and Chief Executive Officer, Sagicor Financial Company Ltd.Mr. Sandberg brings a rare combination of leadership experience across risk, actuarial, pricing, asset-liability management (ALM), and finance, along with annuities expertise,
More news about: Sagicor Life Insurance Company
Apr 29, 2026, 10:12 ET Norgine gibt die Marktzulassung der Europäischen Kommission für XOLREMDI® (Mavorixafor) bekannt, die erste zugelassene Behandlung für Patienten mit WHIM-Syndrom in der Europäischen Union
Behandlung. Erhältlich bei: https://rarediseases.org/rare-diseases/whim-syndrome/. Zugriff im April 20263. Badolato R, Alsina L, Azar A, et al. Eine randomisierte Phase-3-Studie mit Mavorixafor,
More news about: Norgine B.V.
Apr 29, 2026, 10:02 ET Norgine annonce l'autorisation de mise sur le marché par la Commission européenne de XOLREMDI® (mavorixafor), premier traitement autorisé pour les patients atteints du syndrome WHIM dans l'Union européenne.
(CHMP) de l'EMA.L'autorisation de la CE marque une étape importante pour les personnes atteintes de cette immunodéficience primaire très rare et a été accordée dans des circonstances exceptionnelles.Norgine dirigera la commercialisation en Europe dans le cadre de son accord avec
More news about: Norgine B.V.
Apr 29, 2026, 10:00 ET Tsai Capital Introduces Tsai Q-System™ Proprietary Analytical Framework
often create enduring shareholder value. Moreover, our system reinforces our approach: we are perfectly comfortable remaining on the sidelines until the rare alignment of outstanding quality and a meaningful margin of safety surfaces.Ultimately, the Tsai Q-System is simply the formal expression of
More news about: Tsai Capital Corporation
Apr 29, 2026, 10:00 ET Ivo Outperforms Claude for Word in Independent Contract Review Benchmark
at a high level, supporting legal teams by reducing manual workloads and improving efficiency.Objective performance data in legal AI remains rare. This benchmark provides a transparent, real-world evaluation of how purpose-built systems and general AI tools perform on everyday legal work, giving
More news about: Ivo AI, Inc.
Apr 29, 2026, 10:00 ET Penn Medicine and CHOP Name Founding Director for Lurie Autism Institute, Advancing New Era of Autism Research
these structures stop working properly, neurons can be damaged or even die off over time. Dr. Morrow's lab has made important strides in understanding rare inherited conditions – including Christianson syndrome and GPT2 deficiency – shedding light on why certain brain cells are more vulnerable to deterioration
More news about: Children's Hospital of Philadelphia
Apr 29, 2026, 09:49 ET RED PHONE BOOTH HOSTS NATIONWIDE KENTUCKY DERBY WATCH PARTY ON MAY 2
creating a dining experience that pairs seamlessly with the lounge's rare spirits and classic cocktails.The venue also hosts exclusive tasting events led by top industry experts, offering members unique access to rare spirits and curated pairings. With an unwavering commitment to excellence,
More news about: RPB Management Group
Apr 29, 2026, 09:15 ET Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Investigational Stem Cell Therapy for Hemophilia A
autologous stem cell therapy for hemophilia A, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation and Rare Pediatric Disease Designation to its investigational therapy. The dual designations recognize the severity and unmet medical need of hemophilia A —
More news about: Expression Therapeutics, Inc.
Apr 29, 2026, 09:05 ET DMI Solutions Augments Executive Team with Prominent Milk Makeup Co-Founder Dianna Ruth
standout launches such as the Cooling Water Jelly Tint and Hydro Grip Concealer Stick and more than 200 industry awards over her career reflecting a rare ability to consistently translate creative vision into commercially successful innovation.In her role as Chief Innovation Officer at DMI Solutions,
More news about: DMI Solutions
Apr 29, 2026, 09:00 ET Carrum Health Appoints Tech Leadership Duo to Scale AI and Data Capabilities
enhancing the model's impact. For example, AI will only make our care team more effective and every member's experience more personal. Kulesh brings a rare combination of marketplace expertise and an AI-native builder's mindset, critical at this stage as we thoughtfully invest in scaling our platform. Ravi
More news about: Carrum Health
Apr 29, 2026, 09:00 ET Living for the City, New Video Podcast Series Hosted by Hanif Abdurraqib, Premieres May 13th on YouTube and Spotify
generations.Abdurraqib is one of the defining voices in contemporary cultural criticism, known for writing about music, sports, and Black performance with rare literary depth. His work has appeared in The New Yorker, The New York Times, The Fader, and Pitchfork. His books include
More news about: Live Nation Entertainment
Apr 29, 2026, 09:00 ET Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors
successfully navigating through critical stages of growth and value creation," said Oern Stuge MD, MBA, Chairman of the Board of Phagenesis. "He brings a rare combination of clinical insight, strategic perspective, and a track record of building category-defining technologies. His addition strengthens our
More news about: Phagenesis
Apr 29, 2026, 09:00 ET Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors
successfully navigating through critical stages of growth and value creation," said Oern Stuge MD, MBA, Chairman of the Board of Phagenesis. "He brings a rare combination of clinical insight, strategic perspective, and a track record of building category-defining technologies. His addition strengthens our
More news about: Phagenesis
Apr 29, 2026, 09:00 ET C&S Secures Eight-Figure Investment, Led by $10M from Einhorn Collaborative, to Advance Campus Civic Culture
across differences, collaborate with others on issues of shared concern, and become engaged members of their communities. C&S has built something rare: a coalition of presidents willing to lead and implement that change across all facets of their institutions," said Jennifer Hoos Rothberg, executive
More news about: C&S
Apr 29, 2026, 08:43 ET Shaq Wants You to Beat His Lap Time: tm:rw Brings Formula 1 to Times Square Ahead of Miami Grand Prix
Professional racing simulators, rare memorabilia from Hamilton, Senna and Schumacher, and a full-scale McLaren showcar transform New York's innovation destination into an F1 experienceNEW YORK, April 29,
More news about: tm:rw
Apr 29, 2026, 08:35 ET Locksley Provides Update on its Collaboration with Columbia University to Advance Rare Earth Processing Pathways for its Mojave Project in California
Environmental Engineering and Columbia Climate School, is focused on developing potential processing pathways for the recovery, separation and metallization of rare earth elements and associated critical metals from carbonatite and bastnasite style mineral systems, including the mineralization style relevant to
More news about: Locksley Resources
Apr 29, 2026, 08:30 ET WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
has received GMP certification from the Brazilian Health Regulatory Agency (ANVISA).Rare diseases remain a key focus of the Company's platform‑based innovation. As of the end of 2025, there were 23 rare disease projects on our platform. In May 2025, partner CANbridge Pharmaceuticals received approval
More news about: WuXi Biologics
Apr 29, 2026, 08:30 ET TRACE-Funded Corruption Documentary Nominated for Emmy
reporting, the film reveals how the scheme operated, how it was uncovered and the far-reaching consequences that followed. The documentary offers a rare, behind-the-scenes look at the individuals who exposed the scandal—highlighting the risks, challenges, and impact of uncovering corruption at scale."Corruption
More news about: TRACE International
Apr 29, 2026, 08:29 ET Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union
EMA's Committee for Medicinal Products for Human Use (CHMP)EC approval marks a significant milestone for people living with this ultra-rare primary immunodeficiency and was granted under exceptional circumstancesNorgine to lead commercialisation across Europe under its agreement
More news about: Norgine B.V.
Apr 29, 2026, 08:22 ET Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union
for Medicinal Products for Human Use (CHMP)EC approval marks a significant milestone for people living with this ultra-rare primary immunodeficiency and was granted under exceptional circumstancesNorgine to lead commercialisation across Europe
More news about: Norgine B.V.
Apr 29, 2026, 06:00 ET Stanley Black & Decker Reports Strong 1Q 2026 Results
limited to, trade barriers, tariffs, raw material and rare earth related controls, as well as its ability to successfully assess the impact to its business of, and mitigate or respond to, such macroeconomic or trade, tariff and raw material and rare earth import/export control changes, regulations or
More news about: Stanley Black & Decker, Inc.
Apr 29, 2026, 05:22 ET Energenesis Biomedical to Present Clinical Application of ENERGI-F703DFU for Diabetic Foot Ulcers at EWMA 2026
repurposing to address significant unmet medical needs across multiple therapeutic areas, including chronic wounds, neurodegenerative diseases, and rare disorders.The company's leading candidates include:ENERGI-F701 – Tonic for alopecia (Phase II completed)ENERGI-F703DFU
More news about: Energenesis Biomedical Co., Ltd.
Apr 28, 2026, 19:12 ET Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
ImsidolimabImsidolimab is a fully humanized IgG4 monoclonal antibody that inhibits IL-36 receptor signaling and is being developed for GPP, a rare orphan indication. Regulatory and patent exclusivity for imsidolimab is expected to extend into the late 2030s. Vanda holds an exclusive global license
More news about: Vanda Pharmaceuticals Inc.
Apr 28, 2026, 18:41 ET ACTION3統計假設的盲態評估已完成
PARASOL工作組的關鍵分析結論顯示，相較於eGFR（估算腎小球濾過率），蛋白尿指標在FSGS臨床試驗中所需樣本量更少、數據波動更低，能夠有效降低藥物後續在美國上市審批的潛在風險。綜合PARASOL工作組的分析、英國罕見腎髒疾病國家登記處（National Registry of Rare Kidney Diseases UK，簡稱「RaDaR」）的分析、[4] Kaiser Permanente的分析、[5] 第三方FSGS研究數據以及FSGS領域權威專家意見，相較於eGFR相關終點，以蛋白尿基線變化為評估指標，更易在統計學層面驗證D
More news about: Dimerix
Apr 28, 2026, 17:06 ET OFF GRID UNVEILS A NEW STANDARD IN TRACKSIDE HOSPITALITY AT THE MIAMI GRAND PRIX 2026
Week.ULTRA-PREMIUM SPIRITS FROM DIAGEO RARE & EXCEPTIONALThe beverage program, courtesy of the Diageo Rare & Exceptional, spans luxury whiskies, tequilas, and rums from Johnnie Walker, Tequila Don Julio, and Zacapa Rum, alongside rare expressions from iconic single malt Scotch
More news about: Off Grid Hospitality